ANVISA registration 81298810131ActiveGLYCATED HEMOGLOBIN (HbA1C)
ANVISA Registration Number: 81298810131MD CONSULTORIA E COMERCIO DE PRODUTOS PARA LABORATORIO LTDA - METOSOH BIOSCIENCE, INC.Risk Class II
Device names
- Technical name
- GLYCATED HEMOGLOBIN (HbA1C)
- Commercial name
- Hemoglobin A1c Controls - Levels 1 and 2 (Controles para Hemoglobina A1c - Níveis 1 e 2)
- Risk class
- Class II
PT: HEMOGLOBINA GLICADA (HbA1C)
Registration details
- Registration Number
- 81298810131
- Process Number
- 25351382005202042
- CNPJ
- 23000972000181
Company information
- Registration Holder
- MD CONSULTORIA E COMERCIO DE PRODUTOS PARA LABORATORIO LTDA - ME
- Manufacturer
- TOSOH BIOSCIENCE, INC.
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Dec 30, 2020
- Status
- Active
Official value: VIGENTE
About this record
Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81298810131 and manufactured by TOSOH BIOSCIENCE, INC.. The registration is held by MD CONSULTORIA E COMERCIO DE PRODUTOS PARA LABORATORIO LTDA - ME with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.